Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Counsyl | RCV000668230 | SCV000792799 | likely pathogenic | Glucose-6-phosphate transport defect | 2017-07-14 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV000668230 | SCV005729698 | pathogenic | Glucose-6-phosphate transport defect | 2024-04-20 | criteria provided, single submitter | clinical testing | This sequence change creates a premature translational stop signal (p.Phe237Cysfs*4) in the SLC37A4 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in SLC37A4 are known to be pathogenic (PMID: 9758626, 10940311). This variant is present in population databases (rs781869215, gnomAD 0.002%). This variant has not been reported in the literature in individuals affected with SLC37A4-related conditions. For these reasons, this variant has been classified as Pathogenic. |